Steward Partners Investment Advisory’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Steward Partners Investment Advisory’s Portfolio QNTM Stock Details QNTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$21.2K	Hold	4,381	–	–	﹤0.01%	3204
2025 Q4	$32K	Buy	4,381 +1,281	+41%	+$14K	﹤0.01%	2910
2025 Q3	$50.8K	Hold	3,100	–	–	﹤0.01%	2605
2025 Q2	$79.8K	Buy	+3,100	New	+$38.2K	﹤0.01%	2239
2021 Q2	–	Sell	-46	Closed	-$5.73K	–	7447
2021 Q1	$5.73K	Buy	+46	New	+$6.43K	﹤0.01%	2981

Other funds holding QNTM

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

PTP

Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

AUB

Atlantic Union Bankshares Glen Allen, Virginia $5.21B AUM 19.46% 1-Year Est. Return

Steward Partners Investment Advisory's QNTM Position: Q1 2026 in Review

Steward Partners Investment Advisory held its Quantum Biopharma Class B Subordinate Voting Shares (QNTM) position steady in Q1 2026 at 4,381 shares worth $21.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3204.

Steward Partners Investment Advisory first reported a position in QNTM in Q1 2021 and has held it in 5 quarters since. The position peaked at $79.8K in Q2 2025. 25 funds tracked by Wall St. Rank hold QNTM as of Q1 2026.

Steward Partners Investment Advisory held 4,381 shares of Quantum Biopharma Class B Subordinate Voting Shares worth $21.2K as of Q1 2026.
Steward Partners Investment Advisory left its Quantum Biopharma Class B Subordinate Voting Shares share count unchanged in Q1 2026.
Quantum Biopharma Class B Subordinate Voting Shares made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #3204 holding.
Steward Partners Investment Advisory first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q1 2021 and has held it in 5 quarters since.
Steward Partners Investment Advisory's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $79.8K in Q2 2025.
25 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.